Conditional expression of exogenous Bcl‐XS triggers apoptosis in human melanoma cells in vitro and delays growth of melanoma xenografts

No abstract is available for this paper.

• Publication year

  2003

• Venue

  FEBS Letters

• Publication date

  2003-10-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0014-5793(03)01017-2PMID 14572633
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor production in the nude mouse, fibrinolytic activity and cross-reactivity with antimelanoma sera of various human tumor cell lines

  2004cited by this paper
• Induction of cell death by the BH3‐only Bcl‐2 homolog Nbk/Bik is mediated by an entirely Bax‐dependent mitochondrial pathway

  2003cited by this paper
• Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML).

  2003cited by this paper
• Apoptosis and melanoma: molecular mechanisms

  2003cited by this paper
• Bcl‐XL is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy

  2002cited by this paper
• Inducible nitric oxide synthase is expressed in normal human melanocytes but not in melanoma cells in response to tumor necrosis factor-alpha, interferon-gamma, and lipopolysaccharide.

  2002cited by this paper
• Decreased proliferation of human melanoma cell lines caused by antisense RNA against translation factor eIF-4A1

  2002cited by this paper
• Apoptosis A Link between Cancer Genetics and Chemotherapy

  2002cited by this paper
• Bax oligomerization in mitochondrial membranes requires tBid (caspase-8-cleaved Bid) and a mitochondrial protein.

  2002cited by this paper
• Inducible Nitric Oxide Synthase is Expressed in Normal Human Melanocytes but Not in Melanoma Cells in Response to Tumor Necrosis Factor-α, Interferon-γ, and Lipopolysaccharide

  2002cited by this paper
• The bisphosphonate pamidronate induces apoptosis in human melanoma cells in vitro

  2002cited by this paper
• BCL‐2 Proteins: Regulators of the Mitochondrial Apoptotic Program

  2001cited by this paper
• Bax and Bak Coalesce into Novel Mitochondria-Associated Clusters during Apoptosis

  2001cited by this paper
• Ionizing radiation can overcome resistance to TRAIL in TRAIL‐resistant cancer cells

  2001cited by this paper
• The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis.

  2001cited by this paper
• Induction of apoptosis in lung‐cancer cells following bcl‐xL anti‐sense treatment

  2000cited by this paper
• Resistance to CD95/Fas‐induced and ceramide‐mediated apoptosis of human melanoma cells is caused by a defective mitochondrial cytochrome c release

  2000cited by this paper
• Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity.

  2000cited by this paper
• Antiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma

  2000cited by this paper
• BCL-2 family members and the mitochondria in apoptosis.

  1999cited by this paper
• A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells

  1999cited by this paper
• Expression of Bcl-2 family members in human melanocytes, in melanoma metastases and in melanoma cell lines

  1998cited by this paper
• Bcl-2-independent Bcr–Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xL

  1998cited by this paper
• Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors.

  1998cited by this paper
• The Bcl-2 protein family: arbiters of cell survival.

  1998cited by this paper
• Identification of a human cDNA encoding a novel Bcl-x isoform.

  1998cited by this paper
• Bcl-xL Functions Downstream of Caspase-8 to Inhibit Fas- and Tumor Necrosis Factor Receptor 1-induced Apoptosis of MCF7 Breast Carcinoma Cells*

  1998cited by this paper
• Induction of Ceramide-mediated Apoptosis by the Anticancer Phospholipid Analog, Hexadecylphosphocholine*

  1998cited by this paper
• Ceramide signalling: regulatory role in cell proliferation, differentiation and apoptosis in human epidermis

  1997cited by this paper
• Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene.

  1997cited by this paper
• Bcl-2 and Bcl-XL can differentially block chemotherapy-induced cell death.

  1997cited by this paper
• Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases.

  1997cited by this paper
• Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.

  1996cited by this paper
• bcl-xs gene therapy induces apoptosis of human mammary tumors in nude mice.

  1996cited by this paper
• Bcl-x Antagonizes the Protective Effects of Bcl-x(*)

  1996cited by this paper
• Bcl-xS enhances adenoviral vector-induced apoptosis in neuroblastoma cells.

  1996cited by this paper
• Bcl-x(S) anatagonizes the protective effects of Bcl-x(L).

  1996cited by this paper
• An Additional Form of Rat Bcl-x, Bcl-xβ, Generated by an Unspliced RNA, Promotes Apoptosis in Promyeloid Cells*

  1996cited by this paper
• Transcriptional activation by tetracyclines in mammalian cells.

  1995cited by this paper
• Incomplete expression of the tyrosinase gene family (tyrosinase, TRP-1, and TRP-2) in human malignant melanoma cells in vitro.

  1995cited by this paper
• bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death.

  1995cited by this paper
• Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis.

  1995cited by this paper
• A recombinant bcl-x s adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells.

  1995cited by this paper
• Overexpression of Bcl-XS sensitizes MCF-7 cells to chemotherapy-induced apoptosis.

  1995cited by this paper
• Identification of genes specifically regulated in melanoma cells: 266

  1993cited by this paper
• bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death.

  1993cited by this paper
• Proliferation and morphology of melanoma cells and benign human melanocytes under varying culture conditions.

  1993cited by this paper
• Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

  1992cited by this paper
• Glycoprotein P3.58, associated with tumor progression in malignant melanoma, is a novel leukocyte activation antigen

  1988cited by this paper
• Exceptional lethality for nude mice of cells derived from a primary human melanoma.

  1985cited by this paper
• Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens

  1976cited by this paper
• Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells.

  1976cited by this paper
• Characterization of human maligant melanoma cell lines. I. Morphology and growth characteristics in culture.

  1975cited by this paper
• Cell-mediated cytotoxicity for bladder carcinoma: evaluation of a workshop.

  1975cited by this paper
• In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors.

  1973cited by this paper

• Quantitative Analysis of Isoform Switching in Cancer

  2023cites this paper
• Noncoding RNAs regulate alternative splicing in Cancer

  2021cites this paper
• Correction of Bcl‐x splicing improves responses to imatinib in chronic myeloid leukaemia cells and mouse models

  2020cites this paper
• BCL-2 family isoforms in apoptosis and cancer

  2019cites this paper
• Sensitization of human melanoma cells for TRAIL-induced apoptosis by a selective aurora kinase A inhibitor

  2016cites this paper
• Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis

  2016cites this paper
• A Novel Lentiviral Vector Model to Investigate the Mechanism of Insertional Mutagenesis by Aberrant Splicing

  2015cites this paper
• Long non-coding RNA INXS is a critical mediator of BCL-XS induced apoptosis

  2014cites this paper
• 牛肠道病毒 RT -PCR 检测方法的建立及初步应用

  2014cites this paper
• Long non-coding RNA INXS is a critical mediator of BCL-XS induced apoptosis

  2014cites this paper
• Altered mRNA Expression Related to the Apoptotic Effect of Three Xanthones on Human Melanoma SK-MEL-28 Cell Line

  2013cites this paper
• The BH3-only protein Bim(L) overrides Bcl-2-mediated apoptosis resistance in melanoma cells.

  2013cites this paper
• Mutual Regulation of Bcl-2 Proteins Independent of the BH3 Domain as Shown by the BH3-Lacking Protein Bcl-xAK

  2012cites this paper
• Disruption of the VDAC2–Bak interaction by Bcl-xS mediates efficient induction of apoptosis in melanoma cells

  2012cites this paper
• Insights into melanoma: targeting the mTOR pathway for therapeutics

  2012cites this paper
• Antisense Technology: From Unique Laboratory Tool to Novel Anticancer Treatments

  2012cites this paper
• Modification of Bcl-x and Mcl-1 pre-mRNA splicing using splice-switching oligonucleotides

  2011cites this paper
• Etude des mécanismes de mort cellulaire et de résis tance des cellules cancéreuses pour le développement de nouvelles approches thérapeutiques : modèle du mélanome

  2011cites this paper
• Expression of a chemokine BRAK/CXCL14 in oral floor carcinoma cells reduces the settlement rate of the cells and suppresses their proliferation in vivo.

  2010cites this paper
• Antisense treatment in human prostate cancer and melanoma.

  2010cites this paper
• Respuesta al daño al ADN: un ejemplo de acoplamiento entre transcripción y splicing alternativo

  2009cites this paper
• Heterogeneous Nuclear Ribonucleoprotein K Represses the Production of Pro-apoptotic Bcl-xS Splice Isoform

  2009cites this paper
• The BH3-only member Noxa causes apoptosis in melanoma cells by multiple pathways

  2008cites this paper
• Apoptosis induction by Bcl-2 proteins independent of the BH3 domain.

  2008cites this paper
• Expression and Function of Bcl-2 Proteins in Melanoma

  2008cites this paper
• Absence of Bcl-xL down-regulation in response to cisplatin is associated with chemoresistance in ovarian carcinoma cells.

  2007cites this paper
• Apoptosis pathways and oncolytic adenoviral vectors: promising targets and tools to overcome therapy resistance of malignant melanoma

  2007cites this paper
• BH3-only proteins in tumorigenesis and malignant melanoma

  2007cites this paper
• Overcoming apoptosis deficiency of melanoma-hope for new therapeutic approaches.

  2007cites this paper
• Tetracycline Regulated Systems in Functional Oncogenomics

  2007cites this paper
• Proapoptotische Strategien gegen Melanomzellen

  2006cites this paper
• Loss of proapoptotic Bcl-2-related multidomain proteins in primary melanomas is associated with poor prognosis.

  2006cites this paper
• A novel Bcl-x splice product, Bcl-xAK, triggers apoptosis in human melanoma cells without BH3 domain

  2006influential citation
• Tetracycline Regulated Systems in Functional Oncogenomics

  2006cites this paper
• Die Bedeutung der Apoptosekontrolle für das Melanom

  2006cites this paper
• Proapoptotic Strategies against Melanoma Cells

  2006cites this paper
• Proapoptotische Strategien gegen Melanomzellen Proapoptotic Strategies against Melanoma Cells

  2006cites this paper
• بررسی سمیت فرآورده گیاهی ACA1 بر رده سلول سرطانی ملانومای انسانی

  2006cites this paper
• Caspase-independent induction of apoptosis in human melanoma cells by the proapoptotic Bcl-2-related protein Nbk / Bik

  2005cites this paper
• Efficient TRAIL-R1/DR4-mediated apoptosis in melanoma cells by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).

  2005cites this paper
• Selective induction of apoptosis in melanoma cells by tyrosinase promoter-controlled CD95 ligand overexpression.

  2005cites this paper
• Master Author Index

  2004cites this paper